MCTA
Charming Medical Limited (MCTA) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B+); its weakest is Value (D-). The rating has held at C for 2 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-13 | D- (0.8) | D- (0.9) | B+ (3.8) | B- (3.0) | C+ (2.6) | C (2.2) |
| 2026-11-06 | D- (0.8) | D- (0.9) | B+ (3.8) | B- (3.1) | C+ (2.7) | C (2.3) |
| 2026-10-30 | D- (0.8) | D- (0.9) | B+ (3.8) | B- (3.0) | C+ (2.7) | C (2.2) |
| 2026-10-23 | D- (0.8) | D- (0.9) | B+ (3.8) | C+ (2.5) | C+ (2.6) | C- (2.1) |
| 2026-10-16 | D- (0.8) | D- (0.9) | B+ (3.8) | C+ (2.5) | C+ (2.6) | C- (2.1) |